The hypolipidemic action of probucol: a study of its effects on high and low density lipoproteins.
Open Access
- 30 April 1983
- journal article
- research article
- Published by Elsevier in Journal of Lipid Research
- Vol. 24 (5) , 588-595
- https://doi.org/10.1016/s0022-2275(20)37963-3
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesisAtherosclerosis, 1981
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980
- Metabolism of apolipoproteins A-I and A-ll and its influence on the high density lipoprotein subfraction distribution in males and femalesEuropean Journal of Clinical Investigation, 1978
- The Measurement of Apolipoprotein A-I and A-II Levels in Men and Women by ImmunoassayJournal of Clinical Investigation, 1977
- Probucol in the long-term treatment of hypercholesterolaemiaCurrent Medical Research and Opinion, 1973
- The metabolism of low density lipoprotein in familial type II hyperlipoproteinemiaJournal of Clinical Investigation, 1972
- The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observationsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972
- The effect of [4,4′-(isopropylidenedithio)bis(2,6-di-t-butylphenol)] (DH-581) on serum lipids and lipoproteins in human subjectsMetabolism, 1969
- DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS*Annals of the New York Academy of Sciences, 1964
- The Theory of Tracer Experiments with 131I-Labelled Plasma ProteinsPhysics in Medicine & Biology, 1957